The ocular surface is a complex morpho-functional unit in which multiple anatomical and cellular components (cornea, conjunctivae, lacrimal glands, Meibomian glands, tear film, immune cells, and nervous fibers) cooperate to preserve its homeostasis.
1 This equilibrium promotes the repair of the ocular surface following daily repetitive insults.
2,3 In other organs (such as the cardiovascular, endocrine, and nervous systems), the self-limiting innate immune mechanisms that maintain and restore homeostasis have been termed “para-inflammation.”
2 According to this paradigm, para-inflammation is a physiologic process that permits tissues to adapt to injuries and that restores their normal functions.
2 However, if dysregulated, para-inflammation may trigger overt inflammation, resulting in the clinical signs observed in several chronic disorders, such as type 2 diabetes, neurodegenerative and cardiovascular diseases.
4 There is evidence that cumulative age-associated low-grade oxidative insults associated to dysregulation of para-inflammation contribute to age-related macular degeneration.
5 Although an association between aging and ocular surface damage has been presumed, there is no agreement on what constitutes “healthy” aging of ocular surface system. We hypothesize that a persistent dysregulation of para-inflammation: (1) occurs with aging in the ocular surface, (2) compromises homeostasis, and (3) fosters an often asymptomatic inflammatory condition “InflammAging.” InflammAging is a chronic, subclinical form of dysregulated para-inflammation that arises with aging.
6–12 In this prospective cohort study, we assessed clinical and biomolecular changes of the ocular surface in volunteers of different ages who consider themselves healthy, thus investigating InflammAging at ocular surface.